Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-23

FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company, indicating changes to its labeling as part of the appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)

Snippet

SUPPL AP for EPIVIR (LAMIVUDINE)